So far, the effect of rs5104 has been studied only in some small studies: it was associated with dyslipidemia in Han Chinese (25), with postprandial ApoA-I plasma concentration in healthy young men (26) and with triglyceride response to fenofibrate treatment (27). The gene discussed is APOA1; the disease is metabolic syndrome.